tiprankstipranks
Advertisement
Advertisement

Teladoc Shareholders Approve Board, Pay and Auditor

Story Highlights
  • Teladoc Health shareholders re-elected all nine board directors, showing broad but varied support.
  • Investors backed executive pay and re-ratified Ernst & Young, reinforcing Teladoc’s governance stability.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Teladoc Shareholders Approve Board, Pay and Auditor

Meet Samuel – Your Personal Investing Prophet

An update from Teladoc ( (TDOC) ) is now available.

At its 2026 Annual Meeting of Stockholders, held on May 21, 2026, Teladoc Health shareholders elected all nine director nominees to serve until the 2027 Annual Meeting, including Charles Divita III, Sandra L. Fenwick and Mark Douglas Smith. The vote results showed broad, though not unanimous, support across the slate, with some directors drawing higher opposition than others, indicating nuanced investor sentiment toward board composition.

Shareholders also approved on an advisory basis the compensation of Teladoc Health’s named executive officers, signaling general investor backing for current pay practices. In addition, investors ratified Ernst & Young LLP as the company’s independent registered public accounting firm for the fiscal year ending December 31, 2026, reinforcing continuity in Teladoc’s financial oversight and governance framework.

The most recent analyst rating on (TDOC) stock is a Hold with a $6.00 price target. To see the full list of analyst forecasts on Teladoc stock, see the TDOC Stock Forecast page.

Spark’s Take on TDOC Stock

According to Spark, TipRanks’ AI Analyst, TDOC is a Neutral.

The score is driven by strong cash generation but constrained by continued net losses and uneven revenue momentum. Earnings-call takeaways are mixed: reaffirmed full-year guidance and execution in Integrated Care/insurance are positives, while BetterHelp declines and leverage/convertible-note uncertainty remain key risks. Technically, momentum is improving short-term but the stock is still below its 200-day average.

To see Spark’s full report on TDOC stock, click here.

More about Teladoc

Teladoc Health, Inc. is a telehealth company that provides virtual medical services, connecting patients with physicians and other healthcare professionals through digital platforms. The company focuses on remote healthcare delivery, including primary care, mental health, and specialty consultations, serving health plans, employers, and individual consumers in the broader digital health market.

Average Trading Volume: 5,379,094

Technical Sentiment Signal: Sell

Current Market Cap: $1.17B

See more insights into TDOC stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1